The other specific types of diabetes are less common and can be broadly classed as genetic, exocrine pancreatic, endocrine, and drug-induced causes. A more comprehensive breakdown is provided in Table 1.2 and the more common types are discussed briefly later.

Of the new medications for type 2 patients, which one do you prefer most for an overweight type 2 patient with an A1c of 8.5% after putting them on metformin? Follow the link to respond.

A 59-year-old patient who was diagnosed with type 2 diabetes five years ago presents to your clinic for an appointment. He has a history of hypertension and dyslipidemia, both currently well controlled with medication. He has been taking metformin and a DPP-4 inhibitor. He tells you he is concerned about a sore on his foot that is taking a long time to heal. At today’s visit, his office A1C is 8.8%. After discussing his options, you decide to add basal insulin analogue detemir to his regimen. Compared to insulin NPH, what would you expect him to experience while taking detemir? Follow the link to answer.

Meal Memory is a new approach to nutrition tracking. It helps diabetes patients understand how each meal affects them by displaying blood sugar readings from before and after eating.

New study focuses on isolated islets of Langerhans.

Systemic review, network meta-analysis found treatment resulted in greatest reductions in HbA1c, fasting blood glucose, and body weight.

Nearly half of patients with stable A1c, who do not use insulin, found to be unnecessarily tested three to four times a year.

Safety, efficacy of these new classes of diabetic medication require more detailed investigation.

New study showed women accept disease, implement disease management more easily.

In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.